A recent study evaluating biomarkers of inflammation and oxidative stress in a BE cohort report that increased systemic levels of C-reactive protein and to lesser extent IL-6 are associated with progression to EAC supporting the inclusion of these two markers for evaluation in future trials evaluating anti-inflammatory agents conducted in BE patients [64]. The gene discussed is CRP; the disease is Barrett esophagus.